Who Owns OCS?

Oculis Holding AG — Institutional Ownership & 13F Holdings

$27.24

+0.79 (+2.99%)

Market Cap

$1.5B

Shares Outstanding

57,169,500

Institutional Holders

30

Total Inst. Value

$73.0M

% of Float Held

14.8%

QoQ Holder Change

+3

Institutional data as of Q1 2025

New Positions

10

Closed Positions

8

Increased

8

Decreased

4

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Pivotal bioVenture Partners Investment Advisor LLC$43.8M2,300,774
2Nan Fung Group Holdings Ltd$9.8M514,702
3SR ONE CAPITAL MANAGEMENT, LPNew$6.1M322,500
4Alyeska Investment Group, L.P.New$2.5M131,332
5ACUTA CAPITAL PARTNERS, LLCNew$2.4M125,000
6UBS Group AG$2.2M113,455
7Compagnie Lombard Odier SCmA$1.7M87,000
8BANK OF AMERICA CORP /DE/$754K39,634
9MMCAP International Inc. SPC$555K73,525
10NORTHERN TRUST CORP$454K23,832

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold OCS?

As of Q1 2025, 30 institutional investors report holding OCS (Oculis Holding AG) in their 13F filings.

What percentage of Oculis Holding AG is owned by institutions?

Institutional investors hold approximately 14.8% of Oculis Holding AG's float as reported in SEC 13F filings.

Which hedge fund owns the most OCS?

The largest institutional holder of OCS is Pivotal bioVenture Partners Investment Advisor LLC with $43.8M in shares.

Are institutions buying or selling OCS?

This quarter, 10 institutions opened new positions in OCS and 8 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.